Medexus Pharmaceuticals Inc. (TSX: MDP)

Medexus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Year	2022	2021	2020	2019	2018
Net Income	1.22	-2.88	-28.26	-4.4	-4.88
Depreciation & Amortization	6.08	6.15	5.98	3.71	1.93
Share-Based Compensation	1.22	1.88	1.27	1.48	0
Other Operating Activities	-9.96	-6.33	26.05	-2.41	1.01
Operating Cash Flow	-1.44	-1.18	5.04	-1.62	-1.94
Capital Expenditures	-0.36	-7.71	-10.76	-0.84	-0.43
Acquisitions	-1.36	-0.48	-0.95	-27.93	-16.89
Other Investing Activities	-	-	0	0.21	-0
Investing Cash Flow	-1.72	-8.2	-11.7	-28.57	-17.32
Common Stock Issued	0	0	22.64	0	14.99
Share Repurchases	0	0	0	-2.64	0
Other Financing Activities	6.41	0.66	-3.95	11.97	23.39
Financing Cash Flow	6.41	0.66	18.68	14.6	38.38
Net Cash Flow	3.05	-8.69	13.47	-15.36	19.17
Free Cash Flow	-1.81	-8.89	-5.72	-2.46	-2.37
Free Cash Flow Margin	-1.67%	-11.60%	-7.18%	-4.70%	-9.34%
Free Cash Flow Per Share	-0.09	-0.45	-0.38	-0.17	-0.24

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.